ANG and colitis: Strikingly, and consistent with data from Bai et al. [6], they found that administration of exogenous Ang1 both restores the microbiome and mitigates DSS-induced colitis, demonstrating that angiogenin has influential antimicrobial actions that can be utilized therapeutically.